• Hepatology Digest: Advanced hepatocellular carcinoma carries a very bad prognosis, what is the latest developments in terms of biomarkers which can detect this pathology during its early stages.

    《国际肝病》:晚期肝细胞预后极差本病早期生物标志物病理诊断方面有什么进展么

    youdao

  • HEPATOLOGY DIGEST: Recently there were reported studies on the efficacy of sorafenib in treating patients with advanced hepatocellular carcinoma mainly the SHARP trial and the Asia-Pacific study.

    国际肝病最近研究报道索拉尼用于治疗晚期肝癌主要SHARP临床试验亚太地区的试验。

    youdao

  • HEPATOLOGY DIGEST: Recently there were reported studies on the efficacy of sorafenib in treating patients with advanced hepatocellular carcinoma mainly the SHARP trial and the Asia-Pacific study.

    国际肝病最近研究报道索拉尼用于治疗晚期肝癌主要SHARP临床试验亚太地区的试验。

    youdao

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定